$4M Raise for Haoxi Health via Univest Securities
Event summary
- $4M registered direct offering closed for Haoxi Health Technology Ltd by Univest Securities on July 13, 2026.
- Offering included 10M Class A ordinary shares at $0.40 per share or pre-funded warrants.
- Univest acted as sole placement agent in the transaction.
- Proceeds raised under a shelf registration statement (Form F-3) filed June 13, 2025.
The big picture
Univest Securities' role as placement agent underscores its focus on small-cap healthcare tech clients, a niche that has seen increased M&A and financing activity. The $4M raise comes amid tightening liquidity conditions for China-based firms listing in the U.S., making this transaction notable for its execution during a challenging period.
What we're watching
- Execution Risk
- How Haoxi Health will deploy the $4M proceeds to drive growth in China's competitive healthcare marketing sector.
- Market Dynamics
- Whether Univest can sustain its deal flow given recent regulatory scrutiny on small-cap offerings.
- Strategic Fit
- The pace at which Haoxi Health expands beyond short-video marketing into other digital health advertising channels.